Source: Research Seminar 2013 - Optimising models for human lung diseases and drug development



Rating:

Share or cite this content

Citations should be made in the following way:
B. Crestani (Paris, France). Animal models in drug development. Research Seminar 2013 - Optimising models for human lung diseases and drug development

Member's Comments

No comment yet.

Related content which might interest you: Animal studies Source: International Congress 2016 – Is sleep apnoea causing cancer? Year: 2016 Effect of diminazene on monocrotalin-induced pulmonary hypertension rat model Source: International Congress 2015 – Pulmonary hypertension: novel insights into the biology of the disease Year: 2015 Developing a chronic murine model that better reflects the clinical features of the human asthma Source: International Congress 2016 – Pharmacological intervention in humans and murine models of asthma Year: 2016 Animal and physiological settings of IH exposure Source: Eur Respir Monogr 2015; 67: 1-8 Year: 2015 The role of lL-17 in the OVA-LPS driven model of lung inflammation Source: International Congress 2015 – Immune aspects of asthma and other airway diseases Year: 2015 The effect of different PV extracts in the treatment of asthma in an animal model Source: International Congress 2015 – Immune aspects of asthma and other airway diseases Year: 2015 Antioxidant effects of bisphosphonates in smoking- induced lung injury in rat model Source: International Congress 2015 – New models for treating airway diseases Year: 2015 Pre-clinical to clinical potency of AZD7624 in LPS induced TNFa response Source: International Congress 2015 – New targets and modalities for the treatment of asthma and COPD Year: 2015 Regulatory B cell development by helminth-derived antigens Source: International Congress 2015 – Animal studies of asthma and other inflammatory conditions Year: 2015 The effects of clinically relevant reference agents in a mouse model of severe asthma Source: International Congress 2015 – Advances in the future treatment of severe asthma Year: 2015 Tissue distribution of inhalation drugs in rat lung slices Source: International Congress 2015 – New models for treating airway diseases Year: 2015 Validation of a hypertussive model of cough in the rabbit Source: Annual Congress 2013 –Preclinical models for the development of new drugs for respiratory diseases Year: 2013 The neurogenic inflammation markers in rat’s brain in experimental smoking Source: International Congress 2016 – Molecular pathways of smoking-induced diseases Year: 2016 Development of a lung slice methodology to study the mechanisms of lung uptake and lysosomal trapping Source: International Congress 2014 – Novel approaches and evidence for drug development in respiratory diseases Year: 2014 Anti-IgE as an alternative treatment for occupational asthma due to low molecular weight agents Source: International Congress 2016 – Occupational and environmental exposures and biomarkers: human studies, animal data, and in vitro methods Year: 2016 Characterization of a new rat model of heritable PAH Source: International Congress 2016 – Pulmonary hypertension: novel insights Year: 2016